SR2 - Détail SIMDUT

CAS Number : 10124-43-3

WHMIS (Cobalt sulfate)

Workplace Hazardous Materials Information System

WHMIS 2015 classification - Note to reader
Update: 2015-10-06

  • Acute toxicity - oral - Category 41
  • Respiratory sensitization - Category 12 3
  • Skin sensitization - Category 14 5 6 7
  • Carcinogenicity - Category 28
  • Specific target organ toxicity - repeated exposure - Category 19 10 11 12

  • WHMIS 2015 pictogram : Exclamation mark

  • WHMIS 2015 pictogram : Health hazard

Danger

Harmful if swallowed (H302)
May cause allergy or asthma symptoms or breathing difficulties if inhaled (H334)
May cause allergic skin reaction (H317)
Suspected of causing cancer (H351)
Causes damage to organs through prolonged or repeated exposure (H372)

Ingredient disclosure

References

  • ▲1.  National Institute for Occupational Safety and Health, RTECS (Registry of Toxic Effects of Chemical Substances). Hamilton (Ont) : Canadian Centre for Occupational Health and Safety.   http://ccinfoweb.ccohs.ca/rtecs/search.html
  • ▲2.  Shirakawa, T. et al., «Occupational asthma from cobalt sensivity in workers exposed to hard metal dust.» Chest. Vol. 95, no. 1, p. 29-37. (1989). [AP-024259]
  • ▲3.  Baik, J.-J., Yoon, Y.-B. et Park, H.-S., «Cobalt-induced occupational asthma associated with systemic illness.» Journal of Korean Medicine Science. Vol. 10, no. 3, p. 200-204. (1995).
  • ▲4.  Kligman, A.M., «The identification of contact allergens by human assay. III. The maximization test : a procedure for screening and rating contact sensitizers.» Journal of Investigative Dermatology. Vol. 47, no. 5, p. 393-409. (1966). [AP-022756]
  • ▲5.  Romaguera, C. et al., «Photocontact dermatitis to cobalt salts.» Contact Dermatitis. Vol. 8, p. 383-388. (1982). [AP-009053]
  • ▲6.  Sertoli, A. et al., «Unusual contact dermatitis to a cobalt salt.» Contact Dermatitis. Vol. 4, p. 314. (1978). [AP-021544]
  • ▲7.  Bedello, P.G. et al., «Contact dermatitis caused by cobalt naphthenate.» Contact Dermatitis. Vol. 11, no. 4, p. 247. (1984).
  • ▲8.  IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Chlorinated drinking-water; chlorination by-products; so other halogenated compounds; cobalt and cobalt compounds. IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 52. Lyon : International Agency for Research on Cancer. (1991).   https://monographs.iarc.fr/wp-content/uploads/2018/06/mono52.pdf
  • ▲9.  Agency for Toxic Substances and Diseases Registry (ATSDR), , Toxicological profile for cobalt.. ATSDR. Washington D.C. : US Department of Health and Human Services. (2004).   http://www.atsdr.cdc.gov/toxprofiles/index.asp#C http://www.atsdr.cdc.gov/ToxProfiles/tp33.pdf
  • ▲10.  Mohiuddin, S.M. et al., «Experimental cobalt cardiomyopathy.» American heart journal. Vol. 80, no. 4, p. 532-543. (Oct. 1970). [AP-001040]
  • ▲11.  Morvai, V. et al., «The effects of simultaneous alcohol and cobalt chloride administration on the cardiovascular system of rats.» Acta physiologica Hungarica. Vol. 81, no. 3, p. 253-261. (1993). [AP-001041]
  • ▲12.  Grice, H.C. et al., «Myocardial toxicity of cobalt in the rat.» Annals of the New York Academy of Sciences. Vol. 156, no. 1, p. 189-194. (Jan. 1969). [AP-001042]

The [number] refers to the Information SST database of the CNESST Documentation Center.